Other
NT-proBNP testing
NT-proBNP testing is an intervention with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting133%
active_not_recruiting133%
completed133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Point of Care NT-proBNP Testing for Suspected New Heart Failure Acute Care
NCT07793968
recruitingnot_applicable
PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care
NCT07711821
completednot_applicable
NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs
NCT00410293
Clinical Trials (3)
Showing 3 of 3 trials
NCT07793968Not Applicable
Point of Care NT-proBNP Testing for Suspected New Heart Failure Acute Care
NCT07711821Not Applicable
PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care
NCT00410293Not Applicable
NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3